RPS15AP29

Across TCGA pan-cancer cohorts, RPS15AP29 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS15AP29’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RPS15AP29 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS15AP29 is over-expressed in tumor, although a few such as THCA and KIRP show the opposite, repressed pattern.

THCA, COAD, and KIRP are the cancer types where RPS15AP29 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS15AP29 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	All	−0.103	.005	4	view →
COAD	All	II,III,IV	+0.131	.043	2	view →
KIRP	All	IV	−0.112	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPS15AP29–THCA

Open the THCA breakdown →